Stay updated with breaking news from Oene Mark Van. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its target price reduced by Sanford C. Bernstein from $9.00 to $2.50 in a report released on Thursday morning, Benzinga reports. They currently have an outperform rating on the biotechnology company’s stock. A number of other research firms have also weighed in on PACB. Scotiabank cut […]
Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its price objective reduced by Scotiabank from $15.00 to $8.00 in a report published on Thursday, Benzinga reports. They currently have a sector outperform rating on the biotechnology company’s stock. Several other equities research analysts have also weighed in on PACB. Barclays reduced their target price […]
Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its price objective cut by Scotiabank from $15.00 to $8.00 in a report published on Thursday, Benzinga reports. They currently have a sector outperform rating on the biotechnology company’s stock. A number of other research firms also recently weighed in on PACB. The Goldman Sachs Group […]
Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its target price trimmed by Sanford C. Bernstein from $9.00 to $2.50 in a research note released on Thursday morning, Benzinga reports. The firm currently has an outperform rating on the biotechnology company’s stock. A number of other equities research analysts have also recently commented on […]
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report)’s share price gapped up before the market opened on Monday . The stock had previously closed at $3.68, but opened at $3.81. Pacific Biosciences of California shares last traded at $3.69, with a volume of 590,328 shares traded. Analysts Set New Price Targets Several equities […]